[OLGA staging system]
À§Ã༺À§¿°, È»ý¼ºÀ§¿°ÀÇ ÁßÁõµµ ºÐ·ù´Â ¸Å¿ì ´Ù¾çÇÏÁö¸¸ Àú´Â º¸Åë ³»½Ã°æ ¼Ò°ß¿¡ ÀÇÇÑ Kimura ºÐ·ù¸¦ ÁÁ¾ÆÇÕ´Ï´Ù. ÆíÇϱ⠶§¹®ÀÌÁö¿ä. º´¸®°ú ÀÇ»çÀÇ µµ¿òÀ» ¹Þ¾Æ¼ ºÐ·ùÇÏ´Â ¹æ¹ýµµ ¸¹½À´Ï´Ù. ÃÖ±Ù OLGA¶ó´Â ºÐ·ù°¡ Á¦¾ÈµÇ¾ú°í ¸î¸î ¿¬±¸ÀÚµéÀÌ ÀÌ¿ëÇÏ°í ÀÖ½À´Ï´Ù.
Å©°Ô º¸½Ã·Á¸é ±×¸²À» Ŭ¸¯Çϼ¼¿ä.
Á¦°¡ OLGA systemÀ» Àß ¼³¸íµå¸± Á¤µµ·Î ¾ËÁö ¸øÇؼ ±×³É ÀÎÅͳݿ¡ ¶°µµ´Â ¼³¸íÀ» ¿Å±é´Ï´Ù (link).
"Atrophic gastritis (resulting mainly from long-standing Helicobacter pylori infection) is a major risk factor for (intestinal-type) gastric risk.cancer of degree the with correlates significantly changes atrophic the of topography extent/the and development cancer The current format for histology reporting in cases of gastritis fails to establish an immediate link between gastritis phenotype and risk of malignancy. The histology report consequently does not give clinical practitioners and gastroenterologists an explicit message of use in orienting an individual patient¡¯s clinical management. Building on current knowledge of the biology of gastritis and incorporating experience gained worldwide by applying the Sydney System for more than 15 years, an international group of pathologists (Operative Link for Gastritis Assessment) has proposed a system for reporting gastritis in terms of stage (the OLGA staging system). Gastritis staging arranges the histological phenotypes of gastritis along a scale of progressively increasing gastric cancer risk, from the lowest (stage 0) to the highest (stage IV)."
2012³â 12¿ù 1ÀÏ ÇÐȸ¿¡¼ ±¹¸³¾Ï¼¾ÅÍ Á¶¼öÁ¤ ¼±»ý´Ô²²¼ 'Validation of gastritis OLGA-staging system for gastric cancer risk in a region of high prevalence: a case-control stuy'¶ó´Â Á¦¸ñÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´½À´Ï´Ù. °á·ÐÀº 'High OLGA stages are independent risk factor for gastric cancer in a region where incidence of gastric cancer is high'¿´´Âµ¥ ¹«Ã´ Èï¹Ì·Ó½À´Ï´Ù.
[Home]